Dengue vaccin
Generic name
Dengue vaccin
Brand name
ATC Code
J07BX04
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
Pharmacokinetic studies have not been performed
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Active immunization against dengue |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Adverse reactions that were reported more frequently in children than in adults were fever (11% versus 3%), upper respiratory tract infection (11% versus 3%), nasopharyngitis (6% versus 0.6%), pharyngotonsillitis (2% versus 0.3%) and flu-like illness (1% versus 0.1%).
Adverse reactions reported less frequently in children than in adults were erythema at the injection site (2% versus 27%), nausea (0.03% versus 0.8%) and arthralgia (0.03% versus 1%)
In children < 6 years of age: Very often (>10%) decreased appetite, drowsiness, irritability.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
VIRAL VACCINES
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Encephalitis vaccines | ||
|---|---|---|
| J07BA02 | ||
| J07BA01 | ||
| Influenza vaccines | ||
|---|---|---|
| J07BB02 | ||
| Hepatitis vaccines | ||
|---|---|---|
| J07BC20 | ||
| J07BC02 | ||
| J07BC01 | ||
| Measles vaccines | ||
|---|---|---|
| J07BD52 | ||
| Poliomyelitis vaccines | ||
|---|---|---|
| J07BF03 | ||
| Rabies vaccines | ||
|---|---|---|
| J07BG01 | ||
| Rota virus diarrhea vaccines | ||
|---|---|---|
| J07BH01 | ||
| Varicella zoster vaccines | ||
|---|---|---|
| J07BK01 | ||
| Yellow fever vaccines | ||
|---|---|---|
| J07BL01 | ||
| Papillomavirus vaccines | ||
|---|---|---|
| J07BM03 | ||
| J07BM02 | ||
Reference
- Takeda GmbH, SmPC Qdenga (EU/1/22/1699/001) 30-1-2023, www.ema.europa.eu
Changes
Therapeutic Drug Monitoring
Overdose
